Liversidge; Gary

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liversidge; Gary.The latest application filed is for "alcohol resistant enteric pharmaceutical compositions".

Company Profile

0.11.64

Liversidge; Gary - Charlestown MA
Liversidge; Gary - West Chester PA
Liversidge; Gary - Downingtown PA
Liversidge; Gary - Westchester PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Alcohol Resistant Enteric Pharmaceutical Compositions App 20180085315 - Liversidge; Gary ; et al.	2018-03-29
Multiparticulate Modified Release Composition App 20170000783 - Devane; John G. ; et al.	2017-01-05
Injectable Nanoparticulate Olanzapine Formulations App 20150238505 - Ruddy; Stephen B. ; et al.	2015-08-27
Alcohol Resistant Enteric Pharmaceutical Compositions App 20140248341 - Liversidge; Gary ; et al.	2014-09-04
Injectable Nanoparticulate Olanzapine Formulations App 20130309310 - Ruddy; Stephen B. ; et al.	2013-11-21
Nanoparticulate carverdilol formulations Grant 8,367,112 - Liversidge , et al. February 5, 2	2013-02-05
Injectable Nanoparticulate Olanzapine Formulations App 20120315336 - Ruddy; Stephen B. ; et al.	2012-12-13
Controlled-release nanoparticulate compositions Grant 8,293,277 - Swanson , et al. October 23, 2	2012-10-23
Stable Liquid Formulations Of Anti-infective Agents And Adjusted Anti-infective Agent Dosing Regimens App 20120115836 - Liversidge; Gary	2012-05-10
Nanoparticulate Stabilized Anti-hypertensive Compositions App 20120076863 - Jenkins; Scott ; et al.	2012-03-29
Nanoparticulate and controlled release compositions comprising cefditoren Grant 8,119,163 - Devane , et al. February 21, 2	2012-02-21
Compositions For Site-specific Delivery Of Imatinib And Methods Of Use App 20120003319 - Liversidge; Gary ; et al.	2012-01-05
Controlled Release Nanoparticulate Clozapine Compositions App 20110300210 - Swanson; Jon ; et al.	2011-12-08
Alcohol Resistant Enteric Pharmaceutical Compositions App 20110223244 - Liversidge; Gary ; et al.	2011-09-15
Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereof Grant 8,003,127 - Liversidge , et al. August 23, 2	2011-08-23
Injectable Nanoparticulate Olanzapine Formulations App 20110195095 - Liversidge; Gary ; et al.	2011-08-11
Nanoparticulate Bicalutamide Formulations App 20110159054 - Jenkins; Scott ; et al.	2011-06-30
Injectable nanoparticulate olanzapine formulations Grant 7,910,577 - Liversidge , et al. March 22, 2	2011-03-22
Nanoparticulate And Controlled Release Compositions Comprising Vitamin K2 App 20110064803 - Devane; John G. ; et al.	2011-03-17
Nanoparticulate And Controlled Release Compositions Comprising Cyclosporine App 20110064800 - Jenkins; Scott A. ; et al.	2011-03-17
Nanoparticulate and Controlled Release Compositions Comprising Aryl-Heterocyclic Compounds App 20110008435 - Devane; John G. ; et al.	2011-01-13
Nanoparticulate and controlled release compositions comprising cyclosporine Grant 7,825,087 - Jenkins , et al. November 2, 2	2010-11-02
Nanoparticulate and controlled release compositions comprising nilvadipine App 20100247636 - Devane; John G. ; et al.	2010-09-30
Modified Release Famciclovir Compositions App 20100136106 - Liversidge; Gary ; et al.	2010-06-03
Combination Of A Triptan And An Nsaid App 20090311335 - JENKINS; Scott ; et al.	2009-12-17
Aerosol And Injectable Formulations Of Nanoparticulate Benzodiazepine App 20090304801 - Liversidge; Gary ; et al.	2009-12-10
Modified Release Ticlopidine Compositions App 20090297597 - Liversidge; Gary ; et al.	2009-12-03
Modified Release Loxoprofen Compositions App 20090297602 - Devane; John G. ; et al.	2009-12-03
Nanoparticulate and Controlled Release Compositions Comprising a Platelet Aggregation Inhibitor App 20090297596 - Devane; John ; et al.	2009-12-03
Nanoparticulate Bicalutamide Formulations App 20090291142 - JENKINS; Scott ; et al.	2009-11-26
Nanoparticulate and Controlled Release Compositions Comprising a Cephalosporin App 20090269400 - Devane; John ; et al.	2009-10-29
Nanoparticulate and Controlled Release Compositions Comprising Prostaglandin Derivatives App 20090252807 - Jenkins; Scott ; et al.	2009-10-08
Nanoparticulate Anidulafungin Compositions and Methods for Making the Same App 20090238867 - Jenkins; Scott ; et al.	2009-09-24
Compositions For Site-specific Delivery Of Imatinib And Methods Of Use App 20090238884 - Liversidge; Gary ; et al.	2009-09-24
Stable Liquid Formulations Of Anti-infective Agents And Adjusted Anti-infective Agent Dosing Regimens App 20090227554 - Liversidge; Gary	2009-09-10
Injectable Nanoparticulate Olanzapine Formulations App 20090155331 - Ruddy; Stephen B. ; et al.	2009-06-18
Dosing Regimen App 20090149479 - Jenkins; Scott ; et al.	2009-06-11
Nanoparticulate benzothiophene formulations App 20090035366 - Liversidge; Gary ; et al.	2009-02-05
Nanoparticulate Formulations Of Modafinil App 20080317843 - Jenkins; Scott A. ; et al.	2008-12-25
Nanoparticulate and Controlled Release Compositions Comprising Cefditoren App 20080279929 - Devane; John G. ; et al.	2008-11-13
Controlled Release Compositions Comprising an Antipsychotic Agent App 20080268043 - Jenkins; Scott A ; et al.	2008-10-30
Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles App 20080254114 - Jenkins; Scott A. ; et al.	2008-10-16
Nanoparticulate anticonvulsant and immunosuppressive compositions App 20080248123 - Swanson; Jon ; et al.	2008-10-09
Combination Of A Narcotic And Non-narcotic Analgesic App 20080226734 - Jenkins; Scott ; et al.	2008-09-18
Nanoparticulate Sorafenib Formulations App 20080213374 - Carty; Sarah ; et al.	2008-09-04
Nanoparticulate tacrolimus formulations App 20080152720 - Jenkins; Scott ; et al.	2008-06-26
Nanoparticulate and Controlled Release Compositions Comprising Cyclosporine App 20080124389 - Jenkins; Scott A. ; et al.	2008-05-29
Modified Release of Compositions Containing a Combination of Carbidopa, Levodopa and Entacapone App 20080118556 - Devane; John G. ; et al.	2008-05-22
Compositions Comprising Nanoparticulate Naproxen And Controlled Release Hydrocodone App 20080113025 - Devane; John G. ; et al.	2008-05-15
Compositions Comprising Nanoparticulate Meloxicam And Controlled Release Hydrocodone App 20080102121 - Devane; John G. ; et al.	2008-05-01
Controlled Release Compositions Comprising a Cephalosporin for the Treatment of a Bacterial Infection App 20080069870 - Jenkins; Scott A. ; et al.	2008-03-20
Controlled Release Compositions Comprising Levetiracetam App 20070298098 - Jenkins; Scott A. ; et al.	2007-12-27
Nanoparticulate posaconazole formulations App 20070281011 - Jenkins; Scott ; et al.	2007-12-06
Nanoparticulate carverdilol formulations App 20070202180 - Liversidge; Gary ; et al.	2007-08-30
Nanoparticulate and controlled release compositions comprising a cephalosporin App 20070160675 - Devane; John G. ; et al.	2007-07-12
Modified Release Compositions Comprising a Fluorocytidine Derivative for the Treatment of Cancer App 20070122481 - Liversidge; Gary ; et al.	2007-05-31
Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations App 20070065374 - Liversidge; Gary ; et al.	2007-03-22
Controlled release compositions comprising an acylanilide App 20060269596 - Liversidge; Gary ; et al.	2006-11-30
Multiparticulate modified release composition App 20060240105 - Devane; John G. ; et al.	2006-10-26
Nanoparticulate corticosteroid and antihistamine formulations App 20060216353 - Liversidge; Gary ; et al.	2006-09-28
Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof App 20060204588 - Liversidge; Gary ; et al.	2006-09-14
Aerosol and injectable formulations of nanoparticulate benzodiazepine App 20060198896 - Liversidge; Gary ; et al.	2006-09-07
Nanoparticulate formulations of docetaxel and analogues thereof App 20060188566 - Liversidge; Gary ; et al.	2006-08-24
Nanoparticulate candesartan formulations App 20060165806 - Liversidge; Gary ; et al.	2006-07-27
Nanoparticulate benzothiophene formulations App 20060159628 - Liversidge; Gary ; et al.	2006-07-20
Nanoparticulate tacrolimus formulations App 20060159766 - Jenkins; Scott ; et al.	2006-07-20
Nanoparticulate bicalutamide formulations App 20060159767 - Jenkins; Scott ; et al.	2006-07-20
Injectable nanoparticulate olanzapine formulations App 20060154918 - Liversidge; Gary ; et al.	2006-07-13
Topiramate pharmaceutical composition App 20060121112 - Jenkins; Scott A. ; et al.	2006-06-08
Pharmaceutical composition App 20030125347 - Anderson, Kirsten A. ; et al.	2003-07-03
Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents Grant 5,628,981 - Liversidge , et al. May 13, 1	1997-05-13
Barium salt formulations stabilized by non-ionic and anionic stabilizers Grant 5,593,657 - Ruddy , et al. January 14, 1	1997-01-14
Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays Grant 5,585,108 - Ruddy , et al. December 17, 1	1996-12-17
Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers Grant 5,580,579 - Ruddy , et al. December 3, 1	1996-12-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.